Atlas Trials

Fluoxetine to Reduce Intubation and Death After COVID19 Infection

Clinical trial NCT04377308 · COMPLETED

Trial details

NCT number
NCT04377308
Sponsor
University of Toledo Health Science Campus
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19Cytokine Storm
Start date
2020-05-01
Primary completion
2021-04-30
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.